Elevated Circulating CD19+Lymphocytes Predict Survival Advantage in Patients with Gastric Cancer | Zendy

Qi Yu | Zendy; Chuan-ding Yu | Zendy; ZhiQiang Ling | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Elevated Circulating CD19⁺Lymphocytes Predict Survival Advantage in Patients with Gastric Cancer

Author(s) -

Qi Yu,

Chuan-ding Yu,

ZhiQiang Ling

Publication year - 2012

Publication title -

asian pacific journal of cancer prevention

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.512

H-Index - 75

eISSN - 2476-762X

pISSN - 1513-7368

DOI - 10.7314/apjcp.2012.13.5.2219

Subject(s) - medicine , cd19 , proportional hazards model , hazard ratio , lymphocyte , cd8 , gastroenterology , stage (stratigraphy) , cancer , cohort , retrospective cohort study , oncology , immunology , flow cytometry , antigen , confidence interval , biology , paleontology

Circulating lymphocyte subsets reflect the immunological status and might therefore be a prognostic indicator in cancer patients. Our aim was to evaluate the clinical significance of circulating lymphocyte subset in gastric cancer (GC) cases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research